Literature DB >> 28666711

Low high-density lipoprotein cholesterol and particle concentrations are associated with greater levels of endothelial activation markers in Multi-Ethnic Study of Atherosclerosis participants.

Brian T Steffen1, Suzette J Bielinski2, Paul A Decker3, Cecilia Berardi4, Nicholas B Larson3, James S Pankow5, Erin D Michos6, Naomi Q Hanson1, David M Herrington7, Michael Y Tsai8.   

Abstract

BACKGROUND: High-density lipoproteins (HDL) are well characterized for their role in reverse cholesterol transport but may confer other cardiovascular benefits-specifically, HDL may suppress the endothelial activation cascade in the initiating stages of atherogenesis.
OBJECTIVE: It was the primary aim of this study to examine the relations of HDL cholesterol (HDL-C), total HDL particle (HDL-P) concentrations, and HDL-P subclasses with circulating levels of endothelial activation markers in a subcohort of Multi-Ethnic Study of Atherosclerosis participants.
METHODS: HDL-C was measured by enzymatic assay, and total HDL-P and subclass concentrations were assessed by nuclear magnetic resonance spectroscopy. Concentrations of circulating endothelial activation markers were determined through immunoassay. Multivariable linear regression was used to determine the cross-sectional associations between HDL variables and endothelial markers with statistical adjustment for age, race/ethnicity, sex, education, systolic blood pressure, hypertension medication use, body mass index, smoking status, lipid-lowering medication use, serum creatinine, diabetes, low-density lipoprotein cholesterol, and coronary artery calcium.
RESULTS: HDL-C and HDL-P were found to be inversely associated with soluble vascular cell adhesion molecule-1, soluble vascular intracellular adhesion molecule-1, sL-selectin, and sP-selectin; HDL-P was additionally inversely associated with sE-selectin. Participants with low levels of HDL-C (<40 mg/dL) or HDL-P (<25th percentile) showed 3%-12% higher mean levels of soluble vascular cell adhesion molecule and compared with those above these levels (all P < .01).
CONCLUSION: Coupled with previous evidence, our findings suggest a modest to moderate relation of HDL and circulating levels of endothelial activation markers in humans. Whether this relationship may have clinical implications in suppressing atherogenesis or coronary heart disease development requires additional research.
Copyright © 2017 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular adhesion; Endothelial activation; Epidemiology; HDL; Lipoproteins; Nuclear magnetic resonance; Risk factors

Mesh:

Substances:

Year:  2017        PMID: 28666711      PMCID: PMC5568454          DOI: 10.1016/j.jacl.2017.05.018

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  35 in total

1.  Lack of association between low HDL-cholesterol and elevated circulating cellular adhesion molecules in normolipidemic CAD patients and healthy subjects.

Authors:  Natasa Bogavac Stanojević; Zorana Jelić Ivanović; Srdjan Djurovic; Vesna Spasojević Kalimanovska; Slavica Spasić; Dimitra Kalimanovska Ostrić; Lidija Memon
Journal:  Int Heart J       Date:  2005-07       Impact factor: 1.862

2.  Cardioprotective effects of high-density lipoproteins: the evidence strengthens.

Authors:  P J Barter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-07       Impact factor: 8.311

3.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

4.  Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression.

Authors:  Sung-Hee Park; Jung Han Yoon Park; Jung-Sook Kang; Young-Hee Kang
Journal:  Int J Biochem Cell Biol       Date:  2003-02       Impact factor: 5.085

5.  A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells.

Authors:  Bing Pan; Jinge Kong; Jingru Jin; Jian Kong; Yubin He; Shuying Dong; Liang Ji; Donghui Liu; Dan He; Liming Kong; David K Jin; Belinda Willard; Subramaniam Pennathur; Lemin Zheng
Journal:  Biochim Biophys Acta       Date:  2016-03-21

6.  Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.

Authors:  G W Cockerill; T Y Huehns; A Weerasinghe; C Stocker; P G Lerch; N E Miller; D O Haskard
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

7.  Anti-inflammatory effects of apolipoprotein A-I in the rabbit.

Authors:  Sanjay Patel; Belinda A Di Bartolo; Shirley Nakhla; Alison K Heather; Todd W Mitchell; Wendy Jessup; David S Celermajer; Philip J Barter; Kerry-Anne Rye
Journal:  Atherosclerosis       Date:  2010-06-04       Impact factor: 5.162

8.  Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells.

Authors:  P W Baker; K A Rye; J R Gamble; M A Vadas; P J Barter
Journal:  J Lipid Res       Date:  1999-02       Impact factor: 5.922

9.  Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

Authors:  D S Freedman; J D Otvos; E J Jeyarajah; J J Barboriak; A J Anderson; J A Walker
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-07       Impact factor: 8.311

Review 10.  Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium.

Authors:  Giuseppe D Norata; Alberico L Catapano
Journal:  Vasc Health Risk Manag       Date:  2005
View more
  1 in total

1.  The poly-omics of ageing through individual-based metabolic modelling.

Authors:  Elisabeth Yaneske; Claudio Angione
Journal:  BMC Bioinformatics       Date:  2018-11-20       Impact factor: 3.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.